Find clinical trials for Multiple Myeloma in San Diego, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near San Diego, CA, USA:
This is a phase 1, multicenter, open-label study evaluating the safety and efficacy of ruxolitinib, steroids and lenalidomide among MM patients who c...
Phase 1
Encinitas, California, United States and 12 other locations
The purpose of this study is to determine the overall response rate of patients with Multiple Myeloma to the combination of Daratum...
Phase 2
La Jolla, California, United States of America
a phase 1b/2, open-label, multicenter study of GC012F (AZD0120), a CD19/BCMA dual CART-cell therapy, in adult subjects with relapsed/refractory Multiple...
Phase 1, Phase 2
La Jolla, California, United States and 12 other locations
versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple...
Phase 3
San Diego, California, United States and 126 other locations
This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple...
Phase 1
La Jolla, California, United States and 38 other locations
Researchers want to learn if MK-4002 (also known as HPN217) can treat relapsed or refractory multiple myeloma (RRMM). The goals of ...
Phase 1
La Jolla, California, United States and 12 other locations
Phase 1 study comprised of open-label, dose escalation, multiple cohorts of P-BCMA-ALLO1 allogeneic T stem cell memory (Tscm) CAR-T cells in ...
Phase 1
San Diego, California, United States and 14 other locations
and dexamethasone (PVd) in participants with relapsed or refractory multiple myeloma (RRMM) who received between 1 to 3 prior lines...
Phase 3
San Diego, California, United States and 258 other locations
This phase 3 randomized, open-label multicenter trial will compare the efficacy, safety and the impact on health-related quality of life (HR-QoL) of...
Phase 3
Encinitas, California, United States and 93 other locations
The purpose of this study is to evaluate the overall minimal residual disease (MRD) negative rate of participants who receive JNJ-68284528.
Phase 2
San Diego, California, United States and 46 other locations
Clinical trials
Research sites
Resources
Legal